Heart Transplant Clinical Trials
|
Sponsor
|
Lead
|
A three-arm study of immunossuppessants: prograf/rapa/steroids vs. prograf/cellcept/steroids vs. neoral/cellcept/steroids. Study is in the follow-up phase.
|
Fujisawa Healthcare
|
Miller
|
DASH - Donor antigen hyporesponsiveness. Monitors the development of donor antigen-specific hyporeactivity to learn more about the mechanism involved. Study is in the follow-up phase.
|
Kidney Transplant Team, University of Minnesota
|
Miller
|
Enteric-coated MPA vs Cellcept. (same basic drug, different pharmacokinetics). Study is in the follow-up phase.
|
Novartis
|
Miller
|
Cardiac Transplant Research Database (CTRD) is a nation-wide database for heart transplants started by Dr. Leslie Miller while he was at St. Louis. Fairview-University is one of about 40 centers that contribute data on all their heart transplant patients. Through this research they will have the ability to generate much more information on outcomes than any one center could do independently.
|
|
Miller
|
The utility of C2 Cyclosporine Monitoring in Cardiac Transplantation: A Cardiac Transplant Research Database (CTRD) Pilot Study. Enrolling post-transplant patients.
|
UAB through Novartis
|
Miller
|
Heart Failure Clinical Trials
|
Sponsor
|
Lead
|
YM087 in CHF. A randomized, double-blind, placebo-controlled, dose-ranging pilot study evaluating the efficacy and safety of YM087 in patients with decompensated chronic heart failure. Study is in the follow-up phase.
|
Yamanouchi
|
Colvin-Adams
|
The Renaissance Study (RIAF). Study is in the follow-up phase.
|
Immunex Corporation
|
Miller
|
Clinical evaluation of ACORN cardiac support device in patients with dilated cardiomyopathy. Study is in the follow-up phase.
|
ACORN Cardiovascular
|
Miller
|
Revive. Study is in the follow-up phase.
|
Orion Pharmaceuticals
|
Miller
|
Evaluation Study of Congestive Heart Failure and Pulmonary Artery Effectiveness. Study is in the follow-up phase.
|
NIH
|
Miller
|
A phase II, double blind randomized placebo controlled dose comparative study of the efficacy tolerability and safety of MCC 135 in subjects with chronic heart failures. NYHA Class II/III. Study is in the follow-up phase.
|
Mitsubishi Study
|
Miller
|
Clinical Investigation of the DeBakey VAD(R) with Comparison to a Performance Goal to Establish Safety and Effectiveness of the Device as a Left Ventricular Support in Patients Awaiting Cardiac Transplantation.
|
MicroMed Technology, Inc.
|
Miller
|
Randomized Evaluation of Mechanical Assistance for Treatment of Congestive Heart Failure - REMATCH (RIAF). Study is in the follow-up phase.
|
NIH
|
Miller
|
HF-ACTION
|
NIH/Duke Clinical Research Institute
|
Colvin-Adams
|
ACCLAIM: A Multi-Center, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess the Effects of Immune Modulation Therapy (IMT) on Mortality in Patients With Chronic Heart Failure. Soon to start enrolling.
|
Vasogen
|
Colvin-Adams
|
RAPID – A Radomized Controlled Trial of Ultrafiltration for Decompensated Congestive Heart Failure. Now enrolling.
|
CHF Solutions
|
Boyle
|
Clenbuteral: A nonramdomized, Prospective, Single-Center Evaluation of Potential Recovery of Heart Function in Patients with Advanced Heart Failure by Treatment with a Combination o Left Ventricular Assist Device (LVAD), Novel Drug Therapy and Exercise Training. Now enrolling.
|
Thoratec
|
Miller
|
Request
the Video